Aligos Therapeutics Stock Statistic Functions Beta
| ALGS Stock | USD 7.34 0.39 5.61% |
| Symbol |
This analysis covers thirty-seven data points across the selected time horizon. The Beta measures systematic risk based on how returns on Aligos Therapeutics correlated with the market. If Beta is less than 0 Aligos Therapeutics generally moves in the opposite direction as compared to the market. If Aligos Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aligos Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aligos Therapeutics is generally in the same direction as the market. If Beta > 1 Aligos Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Aligos Therapeutics Technical Analysis Modules
Technical analysis of Aligos Therapeutics uses historical price and volume data to identify patterns that may signal where the Aligos trend is heading. The broader market regime is relevant when interpreting Aligos technical signals, as sector-wide moves can dominate individual patterns.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Methodology, Assumptions & Data Sources
The Statistic Functions trend below shows where Aligos Therapeutics stands now versus the past. Year-over-year changes are the easiest way to spot turning points.
This section for Aligos Therapeutics is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules.